Skip to content
Screener

Context Therapeutics Inc. CNTX Q2 2026 earnings

Reported August 5, 2026 · After market close

EPS-$0.15Miss by $0.06
EPS estimate-$0.09

Next report

Nov 4, 2026 (in 2 months)
EPS estimate-$0.09

FAQ

When did Context Therapeutics Inc. report Q2 2026 earnings?
Context Therapeutics Inc. (CNTX) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Context Therapeutics Inc.'s Q2 2026 revenue and EPS?
Context Therapeutics Inc. reported eps of $-0.15 for Q2 2026.
Did Context Therapeutics Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.09 by $0.06.
How did Context Therapeutics Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 66.7% from $-0.09.
Where can I find Context Therapeutics Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-053378) and the 10-Q periodic report (0001628280-26-053347) directly on SEC EDGAR. The filing index links above go to sec.gov.